Paola Betancur
Has grant
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Paola Betancur is an Assistant Professor at the University of California San Francisco, USA. Her research areas focus on cancer biology, particularly the mechanisms of overexpression and therapy resistance, as well as the role of certain gene activations in the immune response. Recently, she has contributed to studies investigating enhancer clusters in cancer and the relationship between super-enhancers and prognosis in breast cancer.
Recent Grants
Grant: Close
Identification of Novel Gene Regulatory Interactions Driving the Immune Evasion Program Through Transcriptional Activation of CD47 in Cancer
Open Date: 2019-09-01
Close Date: 2022-08-01
Articles (4)
Despite efforts to understand breast cancer biology, metastatic disease remains a clinical challenge. Identifying suppressors of breast cancer progression and mechanisms of transition to more invasive phenotypes could provide game changing therapeutic opportunities. Transcriptional deregulation is central to all malignancies, highlighted by the extensive reprogramming of regulatory elements that underlie oncogenic programs. Among these, super-enhancers (SEs) stand out due to their enrichment in genes controlling cancer hallmarks. To reveal novel breast cancer dependencies, we integrated the analysis of the SE landscape with master regulator activity inference for a series of breast cancer cell lines. As a result, we identified T - h elper-inducing Poxviruses and Zinc-finger ( PO Z)/ K rüppel-like factor (ThPOK, ZBTB7B ), a CD4 + cell lineage commitment factor, as a breast cancer master regulator that is recurrently associated with a SE. ThPOK expression is highest in luminal breast cancer but is significantly reduced in the basal subtype. Manipulation of ThPOK levels in cell lines shows that its repressive function restricts breast cancer cells to an epithelial phenotype by suppressing the expression of genes involved in the epithelial-mesenchymal transition (EMT), WNT/β-catenin target genes, and the pro-metastatic TGFβ pathway. Our study reveals ThPOK as a master transcription factor that restricts the acquisition of metastatic features in breast cancer cells.
Year:
2024
Year:
2023
Year:
2022
Year:
2020
Collaborators (4)
Mary Helen Barcellos-Hoff
Professor/Vice Chair
University of California, San Francisco
Laura J. van 't Veer
University of California, San Francisco
Rosalyn Sayaman
Assistant Adjunct Professor
University of California, San Francisco
Julie Saba
Professor
University of California, San Francisco
Make your next move.
Prepare your application
Review drafts before you send them.